Agilon Health Inc (AGL) kicked off at the price of $1.85: Venture capitalists have an exciting new opportunity

A new trading day began on Monday, with Agilon Health Inc (NYSE: AGL) stock price down -6.09% from the previous day of trading, before settling in for the closing price of $1.97. AGL’s price has ranged from $1.50 to $13.28 over the past 52 weeks.

Here's Your FREE Report on the #1 Small-Cap Uranium Stock of '24.

Small-cap Uranium stocks are booming in 2024! The company we're about to show you is the ONLY small-cap stock in the space that benefits from ALL aspects of the global Uranium industry with none of the risks of running a mine. Smart investors will not be hesitating on this one!

Get the FREE Report with all the details here.


Sponsored

During the last 5-year period, the sales growth of Healthcare Sector giant was 53.71%. Meanwhile, its annual earnings per share averaged -17.47%. With a float of $303.29 million, this company’s outstanding shares have now reached $411.96 million.

Let’s determine the extent of company efficiency that accounts for 1117 employees. In terms of profitability, gross margin is -1.22%, operating margin of -6.17%, and the pretax margin is -5.56%.

Agilon Health Inc (AGL) Breakdown of a Key Holders of the stock

As we move forward, let’s examine how large-scale investors are investing in this stock of the Medical Care Facilities Industry. The insider ownership of Agilon Health Inc is 26.39%, while institutional ownership is 80.56%. The most recent insider transaction that took place on Dec 13 ’24, was worth 55,085. In this transaction Director of this company bought 25,000 shares at a rate of $2.20, taking the stock ownership to the 73,166 shares. Before that another transaction happened on Dec 11 ’24, when Company’s Director bought 25,062 for $2.01, making the entire transaction worth $50,269. This insider now owns 66,144 shares in total.

Agilon Health Inc (AGL) Recent Fiscal highlights

Wall Street market experts anticipate that the next fiscal year will bring earnings of -0.05 per share during the current fiscal year.

According to the Wall Street analysts, stocks earnings will be around -17.47% per share during the next fiscal year.

Agilon Health Inc (NYSE: AGL) Trading Performance Indicators

Here are Agilon Health Inc’s current performance indicators. According to the last quarter’s results, the stock had a quick ratio of 1.29. In addition, a publicly-traded company’s price to sales ratio for the trailing twelve months stands at 0.14.

For the trailing twelve months, Company’s Diluted EPS (Earnings per Share) is -0.82, a number that is poised to hit -0.22 in the next quarter and is forecasted to reach -0.35 in one year’s time.

Technical Analysis of Agilon Health Inc (AGL)

Looking closely at Agilon Health Inc (NYSE: AGL), its last 5-days average volume was 3.42 million, which is a drop from its year-to-date volume of 4.83 million. As of the previous 9 days, the stock’s Stochastic %D was 18.87%. Additionally, its Average True Range was 0.21.

During the past 100 days, Agilon Health Inc’s (AGL) raw stochastic average was set at 6.82%, which indicates a significant decrease from 9.43% during the past two weeks. Based on volatility metrics of the stock, it showed a historical volatility of 82.54% in the past 14 days, which was lower than the 113.44% volatility it showed in the past 100 days.

At the time of writing, stock’s 50-day Moving Average is $2.3134, while its 200-day Moving Average is $4.5532. However, in the short run, Agilon Health Inc’s stock first resistance to watch stands at $1.9350. Second resistance stands at $2.0200. The third major resistance level sits at $2.0800. If the price goes on to break the first support level at $1.7900, it is likely to go to the next support level at $1.7300. Now, if the price goes above the second support level, the third support stands at $1.6450.

Agilon Health Inc (NYSE: AGL) Key Stats

With a market capitalization of 798.73 million, the company has a total of 412,018K Shares Outstanding. Currently, annual sales are 4,316 M while annual income is -262,600 K. The company’s previous quarter sales were 1,451 M while its latest quarter income was -117,620 K.